| Issue Date |
Title |
Author(s) |
| 2012 |
Chronic Myelogenous Leukemia Patients with Highly Nilotinib-Resistant BCR-ABL Mutations Demonstrate Similar Efficacy to Dasatinib, but Have a Higher Likelihood of Developing New Mutations in the Event of Clinical Resistance |
Jiang, Qian;Qin, Ya-Zhen;Lai, Yue-Yun;Jiang, Bin;Jiang, Hao;Shi, Hong-Xia;Huang, Xiao-Jun |
| 23-Nov-2021 |
A Clinical Study of 15 Acute Leukemia Patients with Plasmacytoid Dendritic Cells Expansion |
Zhou, Ya-Lan;Wei, Yan;Liu, Xiaohong;Wang, Jing;Jia, Jinsong;Shi, Hong-Xia;Chang, Ying-Jun;Zhao, Xiao-Su;Liu, Yan-Rong;Ruan, Guo-Rui;Huang, Xiao-Jun;Jiang, Hao |
| 2014 |
The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma |
Zhang, Yao;Bao, Li;Lu, Jin;Liu, Kai-Yan;Li, Jin-Lan;Qin, Ya-Zhen;Chen, Huan;Li, Ling-Di;Kong, Yuan;Shi, Hong-Xia;Lai, Yue-Yun;Liu, Yan-Rong;Jiang, Bin;Chen, Shan-Shan;Huang, Xiao-Jun;Ruan, Guo-Rui |
| 2017 |
Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinib |
Qin, Ya-Zhen;Jiang, Qian;Lai, Yue-Yun;Jiang, Hao;Shi, Hong-Xia;Zhao, Xiao-Su;Liu, Yan-Rong;Huang, Xiao-Jun |
| 2019 |
Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study |
Zhu, Xiao-Fan;He, Hai-Long;Wang, Shun-Qing;Tang, Jing-Yan;Han, Bing;Zhang, Dong-Hua;Wu, Li-Qiang;Wu, De-Pei;Li, Wei;Xia, Ling-Hui;Zhu, Huan-Ling;Liu, Feng;Shi, Hong-Xia;Zhang, Xi;Zhou, Fang;Hu, Jian-Da;Fang, Jian-Pei;Chen, Xie-Qun;Ye, Tie-Zhen;Liang, Ying-Min;Jin, Jie;Zhang, Feng-Kui |
| Apr-2021 |
Gastric cancer complicated with hemophagocytic lymphohistiocytosis: case report and a brief review |
Zhou, Yu-Shi;Cui, Yan-Cheng;Yin, Mu-Jun;Xie, Qi-Wei;Shen, Zhan-Long;Shi, Hong-Xia;Ye, Ying-Jiang;Liang, Bin |
| 2018 |
High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy |
Qin, Ya-Zhen;Zhao, Ting;Zhu, Hong-Hu;Wang, Jing;Jia, Jin-Song;Lai, Yue-Yun;Zhao, Xiao-Su;Shi, Hong-Xia;Liu, Yan-Rong;Jiang, Hao;Huang, Xiao-Jun;Jiang, Qian |
| 2011 |
Imatinib Mesylate Is Superior to Allogeneic Hematopoietic Stem Cell Transplantation As the First-Line Therapy for Patients with Chronic Myeloid Leukemia in the Early Chronic Phase |
Jiang, Qian;Xu, Lan-Ping;Liu, Dai-Hong;Liu, Kai-Yan;Jiang, Bin;Zhang, Xiao-hui;Wang, Yu;Chen, Shan-Shan;Mo, Xiao-Dong;Zhao, Xiang-Yu;Chen, Huan;Chen, Yu-Hong;Han, Wei;Jiang, Hao;Qin, Ya-Zhen;Liu, Yan-Rong;Lai, Yue-yun;Shi, Hong-Xia;Lv, Meng;Huang, Xiao Jun |
| 2015 |
Interim Results of a Multi-Center Observational Study of Current Treatment Patterns for Patients with Severe Aplastic Anemia (SAA), Very Severe Aplastic Anemia (VSAA) and Transfusion-Dependent Non-Severe Aplastic Anemia (TD-NSAA) in China |
Zhang, Feng-Kui;Zhu, Xiao-Fan;He, Hai-Long;Wang, Shun-Qing;Tang, Jing-Yan;Zhou, Dao-Bin;Zhang, Dong-Hua;Zhou, Yu-Hong;Wu, De-pei;Li, Wei;Xia, Ling-Hui;Zhu, Huan-Ling;Liu, Feng;Shi, Hong-Xia;Zhang, Xi;Zhou, Fang;Hu, Jian-Da;Fang, Jian-Pei;Chen, Xie-Qun;Ye, Tie-Zhen;Liang, Ying-Min;Jin, Jie |
| 2015 |
Interim Results of a Multi-Center Observational Study of Current Treatment Patterns for Patients with Severe Aplastic Anemia (SAA), Very Severe Aplastic Anemia (VSAA) and Transfusion-Dependent Non-Severe Aplastic Anemia (TD-NSAA) in China |
Zhang, Feng-Kui;Zhu, Xiao-Fan;He, Hai-Long;Wang, Shun-Qing;Tang, Jing-Yan;Zhou, Dao-Bin;Zhang, Dong-Hua;Zhou, Yu-Hong;Wu, De-pei;Li, Wei;Xia, Ling-Hui;Zhu, Huan-Ling;Liu, Feng;Shi, Hong-Xia;Zhang, Xi;Zhou, Fang;Hu, Jian-Da;Fang, Jian-Pei;Chen, Xie-Qun;Ye, Tie-Zhen;Liang, Ying-Min;Jin, Jie |
| 2008 |
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia - Feasibility and safety study |
Huang, Xiao-Jun;Wang, Yu;Liu, Dai-Hong;Xu, Lan-Ping;Chen, Huan;Chen, Yu-Hong;Han, Wei;Shi, Hong-Xia;Liu, Kai-Yan |
| 2013 |
NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes |
Liu, Yan-Rong;Zhu, Hong-Hu;Ruan, Guo-Rui;Qin, Ya-Zhen;Shi, Hong-Xia;Lai, Yue-Yun;Chang, Yan;Wang, Ya-Zhe;Lu, Dan;Hao, Le;Li, Jin-Lan;Li, Ling-Di;Jiang, Bin;Huang, Xiao-Jun |
| Apr-2020 |
Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myeloma |
Wang, Zi-Long;Liu, Yang;Zhou, Ya-Lan;Li, Jin-Lan;Sun, Qiu-Yu;Wu, Li-Xin;Wen, Lei;Lai, Yue-Yun;Liu, Yan-Rong;Chang, Ying-Jun;Shi, Hong-Xia;Liu, Kai-Yan;Huang, Xiao-Jun;Lu, Jin;Ruan, Guo-Rui |
| Aug-2021 |
PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort study |
Tang, Fei-Fei;Lu, Sheng-Ye;Zhao, Xiao-Su;Qin, Ya-Zhen;Liu, Xiao-Hong;Jia, Jin-Song;Wang, Jing;Gong, Li-Zhong;Jiang, Qian;Zhao, Ting;Shi, Hong-Xia;Chang, Ying-Jun;Huang, Xiao-Jun;Jiang, Hao |
| 2013 |
PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes |
Qin, Ya-Zhen;Zhu, Hong-Hu;Liu, Yan-Rong;Wang, Ya-Zhe;Shi, Hong-Xia;Lai, Yue-Yun;Xu, Lan-Ping;Liu, Dai-Hong;Jiang, Qian;Li, Ling-Di;Jiang, Bin;Liu, Kai-Yan;Huang, Xiao-Jun |
| 2018 |
Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre |
Qin, Ya-Zhen;Jiang, Qian;Jiang, Hao;Lai, Yue-Yun;Shi, Hong-Xia;Chen, Wen-Min;Yu, Lu;Huang, Xiao-Jun |
| 2014 |
Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: A comprehensive large-scale study from a single Chinese center |
Qin, Ya-Zhen;Zhu, Hong-Hu;Jiang, Qian;Jiang, Hao;Zhang, Le-Ping;Xu, Lan-Ping;Wang, Yu;Liu, Yan-Rong;Lai, Yue-Yun;Shi, Hong-Xia;Jiang, Bin;Huang, Xiao-Jun |
| 2014 |
Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center |
Qin, Ya-Zhen;Zhu, Honghu;Jiang, Qian;Jiang, Hao;Zhang, Le-Ping;Li, Jin-Lan;Li, Ling-Di;Liu, Yan-Rong;Lai, Yue-Yun;Shi, Hong-Xia;Jiang, Bin;Huang, Xiao-Jun |
| 2011 |
Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison |
Wang, Yu;Liu, Dai-Hong;Xu, Lan-Ping;Liu, Kai-Yan;Chen, Huan;Chen, Yu-Hong;Han, Wei;Shi, Hong-Xia;Huang, Xiao-Jun |
| 23-Nov-2021 |
Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020) |
An, Zhuo-Yu;Wu, Ye-Jun;He, Yun;Zhu, Xiao-Lu;Shi, Hong-Xia;Wang, Chen-Cong;Jiang, Hao;Lu, Jin;Jiang, Qian;Huang, Qiu-Sha;Fu, Hai-Xia;Wang, Feng-Rong;Mo, Xiao-Dong;Wang, Yu;Zhao, Xiang-Yu;Zhang, Yuan-Yuan;Han, Wei;Chen, Huan;Chen, Yao;Yan, Chen-Hua;Wang, Jing-Zhi;Han, Ting-Ting;Chen, Yu-Hong;Cheng, Yi-Fei;Chang, Ying-Jun;Xu, Lan-Ping;Liu, Kai-Yan;Huang, Xiao-Jun;Zhang, Xiaohui |
